Use of Administrative Data to Identify Off-Label Use of Second-Generation Antipsychotics in a Medicaid Population

2013 ◽  
Vol 64 (12) ◽  
pp. 1236-1242 ◽  
Author(s):  
Daniel M. Hartung ◽  
Luke Middleton ◽  
Bentson H. McFarland ◽  
Dean G. Haxby ◽  
Marian S. McDonagh ◽  
...  
Keyword(s):  
Administrative Data ◽  
Second Generation ◽  
Off Label Use ◽  
Off Label ◽  
Second Generation Antipsychotics ◽  
Medicaid Population ◽  
Label Use

Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder

2019 ◽  
Vol 25 (4) ◽  
pp. 318-327 ◽  
Author(s):  
VIRGINIO SALVI ◽  
GIANCARLO CERVERI ◽  
ANDREA AGUGLIA ◽  
SALVATORE CALÒ ◽  
MARIANGELA CORBO ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Second Generation ◽  
Off Label Use ◽  
Off Label ◽  
Second Generation Antipsychotics ◽  
Label Use

P.3.d.013 Off-label use of second generation antipsychotics in psychiatric inpatients: data from the AMSP study group

2008 ◽  
Vol 18 ◽  
pp. S455-S456
Author(s):  
A. Konstantinidis ◽  
A. Kutzelnigg ◽  
U. Moser ◽  
R. Grohmann ◽  
E. Jaquenoud Sirot ◽  
...  
Keyword(s):  
Second Generation ◽  
Psychiatric Inpatients ◽  
Study Group ◽  
Off Label Use ◽  
Off Label ◽  
Second Generation Antipsychotics ◽  
Label Use

Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists

2019 ◽  
pp. 1-15 ◽  
Author(s):  
Andrea Aguglia ◽  
Gianluca Serafini ◽  
Jacopo Nebbia ◽  
Virginio Salvi ◽  
Giovanni Martinotti ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Second Generation ◽  
Borderline Personality ◽  
Published Data ◽  
Off Label Use ◽  
Off Label ◽  
Second Generation Antipsychotics ◽  
Label Use

The guidelines for borderline personality disorder (BPD) treatment suggest non-pharmacological treatment as the first option, but second-generation antipsychotics (SGAs) are among the overprescribed medications. This study aimed to explore Italian psychiatrists’ attitudes toward off-label use of SGAs in BPD. A randomly selected sample of Italian psychiatrists completed a questionnaire regarding off-label prescription of SGAs. Most respondents reported the off-label use of SGAs. Among the reasons supporting the prescription of SGAs, the presence of strong published data was the most determining factor (51.5%). The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SGAs represents a common clinical practice in accordance with a worldwide trend, the use of long-acting injection formulations was considered inappropriate by 69% of psychiatrists in our sample. Our results reiterate the discrepancy between everyday clinical practice and international recommendations, and show how relevant the literature is in off-label drug prescription.

Off-label use of second-generation antipsychotics in borderline personality disorder

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Juan Antonio García-Carmona ◽  
Jorge Simal-Aguado ◽  
María Pilar Campos-Navarro ◽  
Francisco Valdivia-Muñoz ◽  
Alejandro Galindo-Tovar
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Second Generation ◽  
Borderline Personality ◽  
Off Label Use ◽  
Off Label ◽  
Second Generation Antipsychotics ◽  
Label Use

Metabolic Adverse Effects of Off-Label Use of Second-Generation Antipsychotics in the Adult Population: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 87 (9) ◽  
pp. S413-S414
Author(s):  
Sylvie Bowden ◽  
Veronica Tran ◽  
Roshanak Asgariroozbehani ◽  
William Brett McIntyre ◽  
Mahavir Agarwal ◽  
...  
Keyword(s):  
Systematic Review ◽  
Adverse Effects ◽  
Second Generation ◽  
Meta Analysis ◽  
Adult Population ◽  
Off Label Use ◽  
Off Label ◽  
Second Generation Antipsychotics ◽  
Label Use
Sign in / Sign up

Export Citation Format

Share Document